Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.20.4
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:    
Net loss $ (1,154,104) $ (1,659,754)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 372 1,936
Stock-based compensation 85,611 199,052
(Decrease) increase to fair value of derivative (108,944) 40,187
(Increase) decrease in:    
Inventory (47,747) 146,292
Prepaid expenses and other current assets 18,542 33,194
Increase (decrease) in:    
Accounts payable 49,101 (132,007)
Accrued expenses and other liabilities 27,273 49,452
Net cash used in operating activities (1,129,896) (1,321,648)
Cash flows from investing activities:    
Purchases of property and equipment 0 (2,455)
Net cash used in investing activities 0 (2,455)
Cash flows from financing activities:    
Proceeds from issued common stock and warrants, net of financing costs 0 2,167,162
Net cash provided by financing activities 1,050,000 2,167,162
Net (decrease) increase in cash (79,896) 843,059
Cash, beginning of year 959,309 2,180,329
Cash, end of period 879,413 3,023,388
Series 2 convertible notes    
Cash flows from financing activities:    
Proceeds received from Series 2 convertible notes $ 1,050,000 $ 0